SUPERBUGSTHE ROLE OF DIAGNOSTICS EXPLAINED
&
1 of 171 of 17
Superbugs are microorganisms resistant
to drugs that were previously effective.
Before resistanc
e
After re
sistanc
e
2 of 17
WHAT’S MAKING THE PROBLEM WORSE?
Antibiotics
Healthcare
Public
Water supply
Farming
http://www.bbc.co.uk/guides/z8kccdm3 of 17
MOST COMMON DEADLY RESISTANT DISEASES
34 million people are living with
HIV infection, out of which
8 million are receiving
antiretroviral therapy (2011)
Tuberculosis kills more
people globally than any other
infection.
219 million cases of malaria
occurred worldwide and
660,000 people died from the
disease (2010)
Data suggests association
between high levels of
antiretroviral therapy and
increased levels of HIV
resistance.
In 2012 extensively drug-
resistant TB has been
identified in 92 countries.
Determining drug resistance
for malaria is tough, yet
antimalarial resistant variants
have been threatening malaria
control since the ‘70s.
HIV TB MALARIA
Source: WHO report on Antimicrobial resistance 20144 of 17
DETERMINING HEALTH WITH IN VITRO DIAGNOSTICS
Diagnosis Treatment Monitoring
Treatment
Selection
IVD results help
identify a specific
condition, its
development and
treatment selection.
Treatment
decisions such as
medications,
therapy or lifestyle
changes are
prescribed.
Treatment is carried
out using medical
devices or
pharmaceuticals.
IVD results help
check status of a
disease.
Did the treatment work?
YesNo
CURE
5 of 17
Superbugs have no respect
for national borders.
6 of 17
Proper treatment starts with
accurate diagnosis.
7 of 17
“Without urgent, coordinated action by many stakeholders,
the world is headed for a post-antibiotic era, in which common
infections and minor injuries which have been treatable for
decades can once again kill,”
“This is a somewhat grim picture, but I also want to point out
that it’s not a hopeless picture.. if countries and other stakeholders
see this report and respond to this report as a call of action.”
-- Dr Keiji Fukuda,
WHO’s Assistant Director-General
for Health Security.
8 of 17
9 of 17
GREATEST THREATS: MDR-TB*
Total TB cases detected
globally (in millions)
Total of MDR-TB cases confirmed
globally (in thousands)
1990
0
2
4
6
8
10
1995 2000 2005 2010 2011 2012
0
20
40
60
80
100
2005 2010 2011 2012
Source: WHO Global Tuberculosis Report 2013
*Multi-drug resistant tuberculosis
10 of 17
DIAGNOSING MDR-TB
2 WEEKS
2 HOURS
Accelerating time of diagnosis
11 of 17
GREATEST THREATS: HIV
Sources: WHO HIV Drug Resistance Report 2012
European AIDS Conference 2013
CDC Analysis 2013
US: 16% of newly
diagnosed HIV
patients carry
resistant virus
(2010)
Europe: drug-
resistant HIV
increased by 35%
in a decade
(2003-2013)
Eastern Africa:
drug-resistant HIV
increase at 29%
per year (2012)
Southern Africa:
drug- resistant HIV
increase at 14%
per year (2012)
12 of 17
DIAGNOSING D-R HIV*
Phenotypic testingGenotypic testing
Do you have HIV? Do you have drug-resistant HIV?
*Drug-resistant HIV
13 of 17
WHAT ARE PUBLIC BODIES DOING?
2001
16.10.2007
10.09.2013
30.04.2014
20.05.2014
WHO publishes
Global Strategy
for Containment
of Antimicrobial
Resistance
Debate in the
European Parliament
on antibiotic resistance
urges raise of awareness
WHO publishes the first
Global Report on AMR
UK Ministry of Health
publishes 6 year AMR
Strategy
Side-event at WHA on “The Fight
Against Antimicrobial
Resistance: Are Diagnosics
Winning?”
14 of 17
WHAT IS THE INDUSTRY DOING?
Develop tests that are necessary
We work together with governments
and supernational organisations:
Make tests more accessible
and available
Empower healthcare professionals
with data necessary to prescribe
treatment
1.
2.
3.
15 of 17
medtechviews.eu
MedTechViews.eu
is an industry
platform for
dialogue about
medical technologies
between various actors
in healthcare.
Here’s how
Superbugs:
How diagnostics
can help doctors reduce
over-prescription
of antibiotics
Superbugs:
Incentivising medtech
to deliver solutions
Submit your view to info@medtechviews.eu.
Have your views shared with 4000+ readers/month.
Read more about
superbugs on
medtechviews.eu
P R O G R E S S
16 of 17
edma-ivd.eu advameddx.orgglobalmedicaltechnologyalliance.org
17 of 17

More Related Content

PPTX
Evolution of superbug
PPTX
Superbugs
PPTX
[Challenge:Future] Fighting with Superbugs
PPTX
Superbug
DOCX
Superbug
PPTX
biotechnolical approach to treat and prevent the creation of superbug in future
PPTX
ANTIBIOTICS AND SUPERBUGS by Dr.T.V.Rao MD
Evolution of superbug
Superbugs
[Challenge:Future] Fighting with Superbugs
Superbug
Superbug
biotechnolical approach to treat and prevent the creation of superbug in future
ANTIBIOTICS AND SUPERBUGS by Dr.T.V.Rao MD

What's hot (18)

DOCX
AN EPISODE FROM THE ANTIBIOTIC ERA A TIME TO ACT
DOC
Einstein paper draft
PPTX
Black Death and plague: a new understanding
PDF
Fighting the growing threat of antimicrobial resistance webinar
PDF
The Black death - a re-emerging infectious disease
PDF
Study of alterations of bacterial membrane proteins involved in β lactam sens...
PDF
Advanced Antibiotics Against Complicated Infections Part 1
PDF
Antibiotic Resistance as a development and aid issue
PDF
Healthcare associated infections and eskape pathogens
PPTX
Important emerging bacterial zoonotic infections affecting the immunocompromi...
PPTX
Drug resistant Tuberculosis
PPTX
Akash jadhav ppt.
PDF
ARE WE KILLING ANTIBIOTICS?
PPTX
Why it is important
PPTX
Germ's theory and kochs postulates
PPTX
Rate of Antibiotic Resistance Doubles According to Two Studies
PDF
Review article infectious bronchitis virus variants a review of the history c...
DOCX
HOW MICROBES RULE THE WORLD?
AN EPISODE FROM THE ANTIBIOTIC ERA A TIME TO ACT
Einstein paper draft
Black Death and plague: a new understanding
Fighting the growing threat of antimicrobial resistance webinar
The Black death - a re-emerging infectious disease
Study of alterations of bacterial membrane proteins involved in β lactam sens...
Advanced Antibiotics Against Complicated Infections Part 1
Antibiotic Resistance as a development and aid issue
Healthcare associated infections and eskape pathogens
Important emerging bacterial zoonotic infections affecting the immunocompromi...
Drug resistant Tuberculosis
Akash jadhav ppt.
ARE WE KILLING ANTIBIOTICS?
Why it is important
Germ's theory and kochs postulates
Rate of Antibiotic Resistance Doubles According to Two Studies
Review article infectious bronchitis virus variants a review of the history c...
HOW MICROBES RULE THE WORLD?
Ad

Viewers also liked (19)

PPTX
Superbugs-Mechanisms, Control & Utilization
PPTX
Superbug Infection | Dr Jose Poulose
PPTX
Superbugs and Bundles of Care
PDF
R. VILLANO - SUPERBUGS & SUPERDRUGS p.te 5 Technologies and research directions
PPT
NDM-1 SUPERBUG
PPTX
MDR , XDR
PDF
Procurement: The Cornerstone of Market Access in Europe
PDF
20130621 health techsummit
PPTX
R&D as a key driver for disease prevention and treatment: impact on chronic d...
PDF
The Value of Medical Technologies and the Industry that Makes Them
PDF
SMI_Conference_JMF_March2015
PDF
Webinar: Defeating Superbugs: Hospitals on the Front Lines
PPTX
Diagnostic microbiology in Antibiotic policy
PDF
European MedTech Week presentation
PPTX
MEDTECH 2013 Lunch Keynote: Tim Ogilvie, CEO, Peer Insight
PPTX
MEDTECH 2014 Executive Breakfast Presentation
PPTX
Nosocomial infections
PDF
Superbug selection and associated clinical and non clinical
PDF
Medtech Rising 2016
Superbugs-Mechanisms, Control & Utilization
Superbug Infection | Dr Jose Poulose
Superbugs and Bundles of Care
R. VILLANO - SUPERBUGS & SUPERDRUGS p.te 5 Technologies and research directions
NDM-1 SUPERBUG
MDR , XDR
Procurement: The Cornerstone of Market Access in Europe
20130621 health techsummit
R&D as a key driver for disease prevention and treatment: impact on chronic d...
The Value of Medical Technologies and the Industry that Makes Them
SMI_Conference_JMF_March2015
Webinar: Defeating Superbugs: Hospitals on the Front Lines
Diagnostic microbiology in Antibiotic policy
European MedTech Week presentation
MEDTECH 2013 Lunch Keynote: Tim Ogilvie, CEO, Peer Insight
MEDTECH 2014 Executive Breakfast Presentation
Nosocomial infections
Superbug selection and associated clinical and non clinical
Medtech Rising 2016
Ad

Similar to Superbugs and the role of diagnostics explained (20)

PDF
Superbugs and the Role of Diagnostics Explained
PDF
R. Villano-Superbugs & superdrugs-Look back at some super diseases
PPTX
Emergence of Drug resistant microbes PPT By DR.C.P.Prince
PPTX
5) anti microbial resistance
PDF
2018: FIND AMR Strategy
PPTX
Antimicrobial resistance .pptx
PPTX
Resistance to anti-microbial agents
PPTX
antimicrobialresistance-131119064103-phpapp01.pptx
PDF
SUPERBUGS – WHO PAYS THE PRICE GROWING CONCERNS WITH MISUSE OF ANTIBIOTICS
PPTX
Judicious use of antibiotics
PPTX
Antimicrobial resistance, Dr Soumya Dey and Dr Tapas Baikar
PDF
prioritization of pathogens to guide discovery, research and development of n...
PPTX
Antimicrobial resistance global amr 7
PDF
Rapid diagnosis of drug resistant tuberculosis: current perspectives and chal...
PDF
Drug resistant TB – latest developments in epidemiology, diagnostics and mana...
PDF
Understanding Tuberculosis New Apprs To Fighting Against Drug Resist P Cardona
PPT
Threat of antibiotic resistant bacteria to humans
PPTX
Antibiotic resistance a global sensation
PPTX
Anti microbial resistance by Young Pharmacist community
Superbugs and the Role of Diagnostics Explained
R. Villano-Superbugs & superdrugs-Look back at some super diseases
Emergence of Drug resistant microbes PPT By DR.C.P.Prince
5) anti microbial resistance
2018: FIND AMR Strategy
Antimicrobial resistance .pptx
Resistance to anti-microbial agents
antimicrobialresistance-131119064103-phpapp01.pptx
SUPERBUGS – WHO PAYS THE PRICE GROWING CONCERNS WITH MISUSE OF ANTIBIOTICS
Judicious use of antibiotics
Antimicrobial resistance, Dr Soumya Dey and Dr Tapas Baikar
prioritization of pathogens to guide discovery, research and development of n...
Antimicrobial resistance global amr 7
Rapid diagnosis of drug resistant tuberculosis: current perspectives and chal...
Drug resistant TB – latest developments in epidemiology, diagnostics and mana...
Understanding Tuberculosis New Apprs To Fighting Against Drug Resist P Cardona
Threat of antibiotic resistant bacteria to humans
Antibiotic resistance a global sensation
Anti microbial resistance by Young Pharmacist community

Recently uploaded (20)

PPTX
Full Slide Deck - SY CF Talk Adelaide 10June.pptx
PDF
Culturally Sensitive Health Solutions: Engineering Localized Practices (www....
PPTX
Nancy Caroline Emergency Paramedic Chapter 17
PDF
Medical_Biology_and_Genetics_Current_Studies_I.pdf
PDF
Cardiovascular Disease & Obesity - Dr Cliff Wong
PPTX
Nancy Caroline Emergency Paramedic Chapter 14
PDF
crisisintervention-210721062718.presetationdf
PPTX
ANALGESIC AND ANTI-INFLAMMssssssATORY DRUGS.pptx
PDF
crisisintervention-210721062718.presentatiodnf
PPTX
1. FAMILY PLANNING-1-2, nursing students
PPTX
Nancy Caroline Emergency Paramedic Chapter 13
PDF
health promotion and maintenance of elderly
PPTX
OSTEOMYELITIS and OSTEORADIONECROSIS.pptx
PDF
ENT MedMap you can study for the exam with this.pdf
PPTX
FOOD IN RELATION TO NUTRITION AND HEALTH
PPTX
health promotion of infant.pptx for nursing students
PPT
12.08.2025 Dr. Amrita Ghosh_Stocks Standards_ Smart_Inventory Management_GCLP...
PPTX
ACUTE CALCULAR CHOLECYSTITIS: A CASE STUDY
PDF
Back node with known primary managementt
PPTX
Management Basics Applied to Nursing.pptx
Full Slide Deck - SY CF Talk Adelaide 10June.pptx
Culturally Sensitive Health Solutions: Engineering Localized Practices (www....
Nancy Caroline Emergency Paramedic Chapter 17
Medical_Biology_and_Genetics_Current_Studies_I.pdf
Cardiovascular Disease & Obesity - Dr Cliff Wong
Nancy Caroline Emergency Paramedic Chapter 14
crisisintervention-210721062718.presetationdf
ANALGESIC AND ANTI-INFLAMMssssssATORY DRUGS.pptx
crisisintervention-210721062718.presentatiodnf
1. FAMILY PLANNING-1-2, nursing students
Nancy Caroline Emergency Paramedic Chapter 13
health promotion and maintenance of elderly
OSTEOMYELITIS and OSTEORADIONECROSIS.pptx
ENT MedMap you can study for the exam with this.pdf
FOOD IN RELATION TO NUTRITION AND HEALTH
health promotion of infant.pptx for nursing students
12.08.2025 Dr. Amrita Ghosh_Stocks Standards_ Smart_Inventory Management_GCLP...
ACUTE CALCULAR CHOLECYSTITIS: A CASE STUDY
Back node with known primary managementt
Management Basics Applied to Nursing.pptx

Superbugs and the role of diagnostics explained

  • 1. SUPERBUGSTHE ROLE OF DIAGNOSTICS EXPLAINED & 1 of 171 of 17
  • 2. Superbugs are microorganisms resistant to drugs that were previously effective. Before resistanc e After re sistanc e 2 of 17
  • 3. WHAT’S MAKING THE PROBLEM WORSE? Antibiotics Healthcare Public Water supply Farming http://www.bbc.co.uk/guides/z8kccdm3 of 17
  • 4. MOST COMMON DEADLY RESISTANT DISEASES 34 million people are living with HIV infection, out of which 8 million are receiving antiretroviral therapy (2011) Tuberculosis kills more people globally than any other infection. 219 million cases of malaria occurred worldwide and 660,000 people died from the disease (2010) Data suggests association between high levels of antiretroviral therapy and increased levels of HIV resistance. In 2012 extensively drug- resistant TB has been identified in 92 countries. Determining drug resistance for malaria is tough, yet antimalarial resistant variants have been threatening malaria control since the ‘70s. HIV TB MALARIA Source: WHO report on Antimicrobial resistance 20144 of 17
  • 5. DETERMINING HEALTH WITH IN VITRO DIAGNOSTICS Diagnosis Treatment Monitoring Treatment Selection IVD results help identify a specific condition, its development and treatment selection. Treatment decisions such as medications, therapy or lifestyle changes are prescribed. Treatment is carried out using medical devices or pharmaceuticals. IVD results help check status of a disease. Did the treatment work? YesNo CURE 5 of 17
  • 6. Superbugs have no respect for national borders. 6 of 17
  • 7. Proper treatment starts with accurate diagnosis. 7 of 17
  • 8. “Without urgent, coordinated action by many stakeholders, the world is headed for a post-antibiotic era, in which common infections and minor injuries which have been treatable for decades can once again kill,” “This is a somewhat grim picture, but I also want to point out that it’s not a hopeless picture.. if countries and other stakeholders see this report and respond to this report as a call of action.” -- Dr Keiji Fukuda, WHO’s Assistant Director-General for Health Security. 8 of 17
  • 10. GREATEST THREATS: MDR-TB* Total TB cases detected globally (in millions) Total of MDR-TB cases confirmed globally (in thousands) 1990 0 2 4 6 8 10 1995 2000 2005 2010 2011 2012 0 20 40 60 80 100 2005 2010 2011 2012 Source: WHO Global Tuberculosis Report 2013 *Multi-drug resistant tuberculosis 10 of 17
  • 11. DIAGNOSING MDR-TB 2 WEEKS 2 HOURS Accelerating time of diagnosis 11 of 17
  • 12. GREATEST THREATS: HIV Sources: WHO HIV Drug Resistance Report 2012 European AIDS Conference 2013 CDC Analysis 2013 US: 16% of newly diagnosed HIV patients carry resistant virus (2010) Europe: drug- resistant HIV increased by 35% in a decade (2003-2013) Eastern Africa: drug-resistant HIV increase at 29% per year (2012) Southern Africa: drug- resistant HIV increase at 14% per year (2012) 12 of 17
  • 13. DIAGNOSING D-R HIV* Phenotypic testingGenotypic testing Do you have HIV? Do you have drug-resistant HIV? *Drug-resistant HIV 13 of 17
  • 14. WHAT ARE PUBLIC BODIES DOING? 2001 16.10.2007 10.09.2013 30.04.2014 20.05.2014 WHO publishes Global Strategy for Containment of Antimicrobial Resistance Debate in the European Parliament on antibiotic resistance urges raise of awareness WHO publishes the first Global Report on AMR UK Ministry of Health publishes 6 year AMR Strategy Side-event at WHA on “The Fight Against Antimicrobial Resistance: Are Diagnosics Winning?” 14 of 17
  • 15. WHAT IS THE INDUSTRY DOING? Develop tests that are necessary We work together with governments and supernational organisations: Make tests more accessible and available Empower healthcare professionals with data necessary to prescribe treatment 1. 2. 3. 15 of 17
  • 16. medtechviews.eu MedTechViews.eu is an industry platform for dialogue about medical technologies between various actors in healthcare. Here’s how Superbugs: How diagnostics can help doctors reduce over-prescription of antibiotics Superbugs: Incentivising medtech to deliver solutions Submit your view to info@medtechviews.eu. Have your views shared with 4000+ readers/month. Read more about superbugs on medtechviews.eu P R O G R E S S 16 of 17